| Financial Year |
March 31 2023 |
| Monetary Funds |
1,196,127,155.26 |
| Held-for-trading Financial Assets |
37,822,721.00 |
| Notes Receivable |
236,150,265.28 |
| Accounts Receivable |
3,859,717,707.66 |
| Advances to Suppliers |
50,596,144.86 |
| Other Receivables |
137,614,154.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,594,886,667.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
164,873,297.97 |
| Total Current Assets |
10,790,206,338.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,395,158.76 |
| Fixed Assetes |
978,118,169.63 |
| Under-construction Projects |
148,880,864.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
168,759,636.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,751,781.66 |
| Deferred Income Tax Assets |
106,329,540.67 |
| Other Non-Current Assets |
217,177,831.55 |
| Sub-Total of Non-Current Assets |
1,805,854,765.13 |
| Total Assets |
12,596,061,103.24 |
| Short-Term Loans |
4,741,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
564,000,000.00 |
| Accounts Payable |
774,877,774.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,084,125.69 |
| Taxes Payable |
86,035,623.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
182,861,020.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
64,424,667.31 |
| Other Current Liabilities |
162,492,158.23 |
| Sub-Total of Current Liabilities |
6,952,528,306.72 |
| Long-term Loans |
256,000,000.00 |
| Bonds Payable |
900,268,595.74 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,376,032.57 |
| Other Non-Current Liabilities |
23,117,899.13 |
| Sub-Total of Non-Current Liabilities |
1,322,267,921.33 |
| Total Liabilities |
8,274,796,228.05 |
| Paid-In Capital(Or Share Stock) |
418,136,060.00 |
| Capital Surplus |
1,429,352,684.05 |
| Surplus Reserve |
185,080,590.03 |
| LESS:Treasury Stock |
104,572,905.00 |
| Undistributed Profits |
2,204,581,366.51 |
| Minority Stockholder's Interest |
5,912,394.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,315,352,480.87 |
| Owner's Equity（Stockholder's Equity） |
4,321,264,875.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,596,061,103.24 |
